296 related articles for article (PubMed ID: 26606876)
21. Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats.
Uchii M; Kimoto N; Sakai M; Kitayama T; Kunori S
Eur J Pharmacol; 2016 Jul; 783():56-63. PubMed ID: 27063445
[TBL] [Abstract][Full Text] [Related]
22. AT1 receptor blockade prevents the increase in blood pressure and the augmentation of intrarenal ANG II levels in hypertensive Cyp1a1-Ren2 transgenic rats fed with a high-salt diet.
Williams DE; Prieto MC; Mullins JJ; Navar LG; Mitchell KD
Am J Med Sci; 2010 Apr; 339(4):356-61. PubMed ID: 20224314
[TBL] [Abstract][Full Text] [Related]
23. The dual AngII/AVP receptor gene N119S/C163R variant exhibits sodium-induced dysfunction and cosegregates with salt-sensitive hypertension in the Dahl salt-sensitive hypertensive rat model.
Ruiz-Opazo N; Lopez LV; Herrera VL
Mol Med; 2002 Jan; 8(1):24-32. PubMed ID: 11984003
[TBL] [Abstract][Full Text] [Related]
24. Angiotensinogen depletion by high renin levels in hypertensive rats: no evidence for tonic stimulation of angiotensinogen by angiotensin II.
Gahnem F; Camargo MJ; von Lutterotti N; Laragh JH; Sealey JE
J Hypertens; 1995 Jan; 13(1):91-6. PubMed ID: 7759857
[TBL] [Abstract][Full Text] [Related]
25. Renal functional, not morphological, abnormalities account for salt sensitivity in Dahl rats.
Manger WM; Simchon S; Stokes MB; Reidy JJ; Kumar AR; Baer L; Gallo G; Haddy FJ
J Hypertens; 2009 Mar; 27(3):587-98. PubMed ID: 19330919
[TBL] [Abstract][Full Text] [Related]
26. Orally active epoxyeicosatrienoic acid analog attenuates kidney injury in hypertensive Dahl salt-sensitive rat.
Hye Khan MA; Neckár J; Manthati V; Errabelli R; Pavlov TS; Staruschenko A; Falck JR; Imig JD
Hypertension; 2013 Nov; 62(5):905-13. PubMed ID: 23980070
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of cortical COX-2 in salt-sensitive hypertension: role of angiotensin II and reactive oxygen species.
Jaimes EA; Zhou MS; Pearse DD; Puzis L; Raij L
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F385-92. PubMed ID: 18094033
[TBL] [Abstract][Full Text] [Related]
28. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.
Nagase M; Shibata S; Yoshida S; Nagase T; Gotoda T; Fujita T
Hypertension; 2006 Jun; 47(6):1084-93. PubMed ID: 16636193
[TBL] [Abstract][Full Text] [Related]
29. Aberrant ENaC activation in Dahl salt-sensitive rats.
Kakizoe Y; Kitamura K; Ko T; Wakida N; Maekawa A; Miyoshi T; Shiraishi N; Adachi M; Zhang Z; Masilamani S; Tomita K
J Hypertens; 2009 Aug; 27(8):1679-89. PubMed ID: 19458538
[TBL] [Abstract][Full Text] [Related]
30. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
31. Angiotensin II receptor antagonist delays renal damage and stroke in salt-loaded Dahl salt-sensitive rats.
von Lutterotti N; Camargo MJ; Campbell WG; Mueller FB; Timmermans PB; Sealey JE; Laragh JH
J Hypertens; 1992 Sep; 10(9):949-57. PubMed ID: 1328376
[TBL] [Abstract][Full Text] [Related]
32. Enhanced central hypertonic saline-induced activation of angiotensin II-sensitive neurons in the anterior hypothalamic area of spontaneously hypertensive and Dahl S rats.
Kubo T; Hagiwara Y
Brain Res Bull; 2006 Jan; 68(5):335-40. PubMed ID: 16377440
[TBL] [Abstract][Full Text] [Related]
33. Blood pressure, magnesium and other mineral balance in two rat models of salt-sensitive, induced hypertension: effects of a non-peptide angiotensin II receptor type 1 antagonist.
Rondón LJ; Marcano E; Rodríguez F; del Castillo JR
Magnes Res; 2014; 27(3):113-30. PubMed ID: 25560239
[TBL] [Abstract][Full Text] [Related]
34. Carbonyl stress induces hypertension and cardio-renal vascular injury in Dahl salt-sensitive rats.
Chen X; Mori T; Guo Q; Hu C; Ohsaki Y; Yoneki Y; Zhu W; Jiang Y; Endo S; Nakayama K; Ogawa S; Nakayama M; Miyata T; Ito S
Hypertens Res; 2013 Apr; 36(4):361-7. PubMed ID: 23364337
[TBL] [Abstract][Full Text] [Related]
35. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
Kawarazaki H; Ando K; Nagae A; Fujita M; Matsui H; Fujita T
Nephrol Dial Transplant; 2010 Sep; 25(9):2879-89. PubMed ID: 20466668
[TBL] [Abstract][Full Text] [Related]
36. Cardiac hypertrophy in the Dahl rat is associated with increased tyrosine phosphorylation of several cytosolic proteins, including a 120 kDa protein.
Rabkin SW; Damen JE; Goutsouliak V; Krystal G
Am J Hypertens; 1996 Mar; 9(3):230-6. PubMed ID: 8695021
[TBL] [Abstract][Full Text] [Related]
37. Sex-specific effects of dual ET-1/ANG II receptor (Dear) variants in Dahl salt-sensitive/resistant hypertension rat model.
Kaneko Y; Herrera VL; Didishvili T; Ruiz-Opazo N
Physiol Genomics; 2005 Jan; 20(2):157-64. PubMed ID: 15561758
[TBL] [Abstract][Full Text] [Related]
38. Mechanistic analysis of renal protection by angiotensin converting enzyme inhibitor in Dahl salt-sensitive rats.
Hirawa N; Uehara Y; Kawabata Y; Ohshima N; Ono H; Nagata T; Gomi T; Ikeda T; Goto A; Yagi S
J Hypertens; 1994 Aug; 12(8):909-18. PubMed ID: 7814850
[TBL] [Abstract][Full Text] [Related]
39. ELABELA antagonizes intrarenal renin-angiotensin system to lower blood pressure and protects against renal injury.
Xu C; Wang F; Chen Y; Xie S; Sng D; Reversade B; Yang T
Am J Physiol Renal Physiol; 2020 May; 318(5):F1122-F1135. PubMed ID: 32174138
[TBL] [Abstract][Full Text] [Related]
40. Thromboxane synthase and TP receptor mRNA in rat kidney and brain: effects of salt intake and ANG II.
Wilcox CS; Welch WJ
Am J Physiol Renal Physiol; 2003 Mar; 284(3):F525-31. PubMed ID: 12517736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
